ABSTRACT-The role of mucosal sulfhydryl (SH) in the pathogenesis of indomethacin induced gastric lesions was investigated in rats. Indomethacin (25 mg/kg, s.c.) caused high-amplitude gastric contractions, resulting in linear hemorrhagic lesions in the cor pus mucosa within 4 hr, but did not induce any changes in the mucosal SH levels. These lesions were prevented significantly by prior s.c. administration of cysteamine, glutathione (GSH) or diethylmaleate (DEM), irrespective of whether the mucosal SH was increased by the former two agents or reduced by the latter. N-Ethylmaleimide (NEM) tended to worsen such lesions without any effect on the mucosal SH contents. Gastric hypermotility caused by indomethacin was inhibited significantly by DEM, cysteamine and GSH, while acid secretion was reduced by DEM and NEM. Both cysteamine and GSH prevented the indomethacin-induced linear lesions even in the stomach perfused with 150 mM HC1, whereas in the animals treated with DEM, non linear damage was induced exclusively in the antrum by indomethacin in the presence of acid. We conclude that the mucosal SH has no relation to the ulcerogenicity of in domethacin in the gastric corpus mucosa.The mechanisms of gastric protection are considered to involve at least two endogenous mediators such as prostaglandins (PGs) and sulfhydryl (SH) substances in the mucosa (1). Participation of PGs has been demonstrated in various experimental ulcer models (2-4), while the role of SH has been exclusively studied in relation to gastric cytoprotection against necrotizing agents (5-7). Since en dogenous SH substances, mainly present as in tracellular glutathione (GSH), have a variety of actions in the body (8), they might have roles in the development of other lesion mod els which have different pathogenetic mecha nisms. In fact, Konturek et al. (9) recently re ported the involvement of mucosal SH in the pathogenesis of stress ulcers. Yet, it remains undetermined whether the mucosal SH has some relation to indomethacin-induced gastric lesions.In the present study, we thus examined the effect of an ulcerogenic dose of indomethacin on the mucosal SH levels in the rat stomach, and investigated the relationship of endo genous SH to the ulcerogenicity of this agent by modulating the mucosal SH levels using SH-related compounds (cysteamine and GSH), an SH alkylator (N-ethylmaleimide) or an SH depletor (diethylmaleate).